The Korean journal of internal medicine

  • 제27권1호
  • /
  • Pages.84-90
  • /
  • 2012
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Effects of Add-On Therapy with NDC-052, an Extract from Magnoliae Flos, in Adult Asthmatic Patients Receiving Inhaled Corticosteroids

  • Park, Chan-Sun (Department of Internal Medicine, Heaundae Paik Hospital, Inje University) ;
  • Kim, Tae-Bum (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Jae-Young (Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University College of Medicine) ;
  • Park, Jae-Yong (Department of Internal Medicine, Kyungpook National University Hospital) ;
  • Lee, Yong-Chul (Department of Internal Medicine, Research Center for Pulmonary Disorders, Research Institute of Clinical Medicine, Chonbuk National University Medical School) ;
  • Jeong, Seong-Su (Department of Internal Medicine, Chungnam National University Hospital) ;
  • Lee, Yang-Deok (Department of Internal Medicine, Eulji University School of Medicine) ;
  • Cho, You-Sook (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Moon, Hee-Bom (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • 발행 : 2012.03.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: There is a need for new anti-asthmatic medications with fewer side effects. NDC-052, an extract of the medicinal herb Magnoliae flos, which has a long history of clinical use, was recently found to have anti-inflammatory effects. Herein, we evaluated the effects of NDC-052 as an add-on therapy in patients with mild to moderate asthma using inhaled corticosteroids (ICS). Methods: In a non-comparative, multi-center trial, 148 patients taking ICS received NDC-052 for eight weeks. We evaluated their forced expiratory volume in one second (FEV1), morning and evening peak expiratory flow rate (AM and PM PEFR), AM/PM asthma symptom scores, visual analogue symptom (VAS) scores, night-time wakening, frequency of short-acting ${\beta}2-agonist$ usage, and adverse events. Results: After eight weeks, both AM and PM PEFRs were significantly improved. Asthma symptom scores, VAS scores, the frequency of nights without awakening, and the frequency of ${\beta}2-agonist$ use were also reduced. Most of the adverse drug reactions were mild and resolved spontaneously. Conclusions: The addition of NDC-052 to ICS had a beneficial effect on asthma control in patients with mild to moderate asthma, with good tolerability and fewer side effects. Further studies are necessary to evaluate the effects of NDC-052 in patients with severe and/or refractory asthma.

키워드

참고문헌

  1. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996;9:636-642. https://doi.org/10.1183/09031936.96.09040636
  2. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-478. https://doi.org/10.1111/j.1398-9995.2004.00526.x
  3. National Institutes of Health, National Heart, Lung, and Blood Institute. National asthma education and prevention program: global strategy for asthma management and prevention. Global Initiative for Asthma report [Internet]. National Institutes of Health, National Heart, Lung, and Blood Institute, 2009 [cited 2011 Dec 20]. Available from http://www.ginasthma.org.
  4. Jang AS. Inhaled steroids in asthma therapy: an update. Korean J Med 2011;80:129-134.
  5. Visser MJ, van der Veer E, Postma DS, et al. Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J 2004;24:420-425. https://doi.org/10.1183/09031936.04.00023904
  6. Eid N, Morton R, Olds B, Clark P, Sheikh S, Looney S. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate. Pediatrics 2002;109:217-221. https://doi.org/10.1542/peds.109.2.217
  7. Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann Allergy Asthma Immunol 2001;87:379-385. https://doi.org/10.1016/S1081-1206(10)62918-3
  8. Li XM. Traditional Chinese herbal remedies for asthma and food allergy. J Allergy Clin Immunol 2007;120:25-31. https://doi.org/10.1016/j.jaci.2007.04.030
  9. Shen Y, Li CG, Zhou SF, Pang EC, Story DF, Xue CC. Chemistry and bioactivity of Flos Magnoliae, a Chinese herb for rhinitis and sinusitis. Curr Med Chem 2008;15:1616-1627. https://doi.org/10.2174/092986708784911515
  10. Chen CC, Huang YL, Chen HT, Chen YP, Hsu HY. On the Ca++- antagonistic principles of the flower buds of Magnolia fargesii. Planta Med 1988;54:438-440. https://doi.org/10.1055/s-2006-962492
  11. Jung KY, Kim DS, Oh SR, et al. Magnone A and B, novel anti-PAF tetrahydrofuran lignans from the flower buds of Magnolia fargesii. J Nat Prod 1998;61:808-811. https://doi.org/10.1021/np970445+
  12. Ahn KS, Jung KY, Kim JH, Oh SR, Lee HK. Inhibitory activity of lignin components from the flower buds of Magnoliae fargesii on the expression of cell adhesion molecules. Biol Pharm Bull 2001;24:1085-1087. https://doi.org/10.1248/bpb.24.1085
  13. Baek JA, Lee YD, Lee CB, et al. Extracts of Magnoliae flos inhibit inducible nitric oxide synthase via ERK in human respiratory epithelial cells. Nitric Oxide 2009;20:122-128. https://doi.org/10.1016/j.niox.2008.10.003
  14. Brightling CE, Monterio W, Green RH, et al. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med 2001;95:999-1002. https://doi.org/10.1053/rmed.2001.1195
  15. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Noneosinophilic corticosteroid unresponsive asthma. Lancet 1999;353:2213-2214. https://doi.org/10.1016/S0140-6736(99)01813-9
  16. The Uppsala Monitoring Centre. The use of the WHO-UMC system for standardized case causality assessment [Internet]. Uppsala: The Uppsala Monitoring Centre, 2010 [cited 2011 Dec 20]. Available from: http://who-umc.org/Graphics/24734.pdf.
  17. Bielory L, Lupoli K. Herbal interventions in asthma and allergy. J Asthma 1999;36:1-65. https://doi.org/10.3109/02770909909065150
  18. Li XM, Zhang TF, Sampson H, et al. The potential use of Chinese herbal medicines in treating allergic asthma. Ann Allergy Asthma Immunol 2004;93(2 Suppl 1):S35-S44. https://doi.org/10.1016/S1081-1206(10)61485-8
  19. Iida T, Nakano M, Ito K. Hydroperoxysesquiterpene and lignan constituents of Magnolia kobus. Phytochemistry 1982;21:673-675. https://doi.org/10.1016/0031-9422(82)83163-4
  20. Pan JX, Hensens OD, Zink DL, Chang MN, Hwang SB. Lignans with platelet activating factor antagonist activity from Magnolia biondii. Phytochemistry 1987;26:1377-1379. https://doi.org/10.1016/S0031-9422(00)81816-6
  21. Chae SH, Kim PS, Cho JY, et al. Isolation and identification of inhibitory compounds on TNF-alpha production from Magnolia fargesii. Arch Pharm Res 1998;21:67-69. https://doi.org/10.1007/BF03216755
  22. Huang YL, Chen CC, Chen YP, Hsu HY, Kuo YH. (-)-Fargesol, a new lignan from the flowers buds of Magnolia fargesii. Planta Med 1990;56:237-238. https://doi.org/10.1055/s-2006-960938
  23. Jung KY, Oh SR, Park SH, et al. Anti-complement activity of tiliroside from the flower buds of Magnolia fargesii. Biol Pharm Bull 1998;21:1077-1078. https://doi.org/10.1248/bpb.21.1077
  24. Kim HM, Yi JM, Lim KS. Magnoliae flos inhibits mast celldependent immediate-type allergic reactions. Pharmacol Res 1999;39:107-111. https://doi.org/10.1006/phrs.1998.0414
  25. Price DB, Hernandez D, Magyar P, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;58:211-216. https://doi.org/10.1136/thorax.58.3.211
  26. Vaquerizo MJ, Casan P, Castillo J, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003;58:204-210. https://doi.org/10.1136/thorax.58.3.204
  27. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med 1998;157(3 Pt 2):S1-S53. https://doi.org/10.1164/ajrccm.157.3.157315
  28. Holt S, Suder A, Weatherall M, Cheng S, Shirtcliffe P, Beasley R. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 2001;323:253-256. https://doi.org/10.1136/bmj.323.7307.253
  29. Vanacker NJ, Palmans E, Pauwels RA, Kips JC. Effect of combining salmeterol and fluticasone on the progression of airway remodeling. Am J Respir Crit Care Med 2002;166:1128-1134. https://doi.org/10.1164/rccm.200203-191OC

피인용 문헌

  1. Suppressive effects of fructus of Magnolia denudata on IL-4 and IL-13 expression in T cells vol.49, pp.10, 2012, https://doi.org/10.1007/s11626-013-9670-9
  2. The Indispensable Value of Clinical Trials in the Modernization of Traditional Chinese Medicine: 12 Years' Experience at CUHK and Future Perspectives vol.42, pp.3, 2012, https://doi.org/10.1142/s0192415x14500384
  3. Inhalation of Shin-I essential oil enhances lactate clearance in treadmill exercise vol.4, pp.2, 2012, https://doi.org/10.1016/s2221-1691(14)60225-2
  4. Herbal treatment in asthma and COPD - current evidence vol.1, pp.None, 2012, https://doi.org/10.1186/s40816-015-0005-0
  5. Herbal Medicines for Asthmatic Inflammation: From Basic Researches to Clinical Applications vol.2016, pp.None, 2016, https://doi.org/10.1155/2016/6943135
  6. Solving the puzzle: What is behind our forefathers’ anti-inflammatory remedies? vol.6, pp.1, 2012, https://doi.org/10.5455/jice.20161204021732
  7. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents vol.18, pp.3, 2012, https://doi.org/10.1631/jzus.b1600299
  8. Neolignan Derivatives from the Flower of Magnolia biondii Pamp. and their Effects on IL-2 expression in T-cells vol.23, pp.2, 2017, https://doi.org/10.20307/nps.2017.23.2.119
  9. Therapeutic Effects of Kangzhi Syrup in a Guinea Pig Model of Ovalbumin-Induced Cough Variant Asthma vol.2018, pp.None, 2012, https://doi.org/10.1155/2018/5867835
  10. Lignans Isolated From Flower Buds of Magnolia fargesii Attenuate Airway Inflammation Induced by Cigarette Smoke in vitro and in vivo vol.9, pp.None, 2018, https://doi.org/10.3389/fphar.2018.00970
  11. Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin vol.24, pp.4, 2012, https://doi.org/10.1158/1078-0432.ccr-17-0345
  12. Differential Toxicity of the Water and Ethanol Extracts of Chung-Sang, an Experimental Herbal Formula vol.32, pp.4, 2012, https://doi.org/10.15188/kjopp.2018.08.32.4.255
  13. COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? vol.11, pp.None, 2020, https://doi.org/10.3389/fphar.2020.581840
  14. Tetrahydrofurofuranoid Lignans, Eudesmin, Fargesin, Epimagnolin A, Magnolin, and Yangambin Inhibit UDP-Glucuronosyltransferase 1A1 and 1A3 Activities in Human Liver Microsomes vol.13, pp.2, 2012, https://doi.org/10.3390/pharmaceutics13020187
  15. Two new phenylpropanoids and a new dihydrostilbenoid from the flower buds of Magnolia biondii pamp and their acetylcholinesterase inhibitory activities vol.35, pp.19, 2012, https://doi.org/10.1080/14786419.2019.1693567